Lexeo Therapeutics (LXEO) Return on Capital Employed [ROCE] (2023 - 2026)
Lexeo Therapeutics (LXEO) reported Return on Capital Employed [ROCE] of -40.14% for Q2 2026, up 63.32 percentage points from -103.46% a year earlier but down 0.29 percentage points from the prior quarter.
Powered by 
Analysis
Lexeo Therapeutics (LXEO) Return on Capital Employed [ROCE] (2023 - 2026) Analysis & Trends
For FY2025, Lexeo Therapeutics posted Return on Capital Employed [ROCE] of -57.20%, up 30.55 percentage points from FY2024.
- By year, Return on Capital Employed [ROCE] came in at -87.75% in FY2024 (-20.05 pp) and -67.70% in FY2023.
- Five-year quarterly Return on Capital Employed [ROCE] spans a low of -110.23% in Q1 2025 and a high of -39.86% in Q1 2026.
- Year over year, Return on Capital Employed [ROCE] has now increased in each of the last three quarters, with an average year-over-year change of +2.81 percentage points over the last seven quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at -39.86% (Q1 2026), -57.67% (Q4 2025) and -79.56% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 35.41% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 17.52% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 21.60% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 4.65% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 9.91% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 17.37% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | -6.15% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 11.32% |
| 10 | Lexeo Therapeutics | 240.59 Mn | -419.82 Mn | - | -40.14% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -40.14% |
| Mar 31, 2026 | -39.86% |
| Dec 31, 2025 | -57.67% |
| Sep 30, 2025 | -79.56% |
| Jun 30, 2025 | -103.46% |
| Mar 31, 2025 | -110.23% |
| Dec 31, 2024 | -76.89% |
| Sep 30, 2024 | -59.80% |
| Jun 30, 2024 | -44.68% |
| Mar 31, 2024 | -46.82% |
| Dec 31, 2023 | -85.61% |
API Access
Lexeo Therapeutics Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "LXEO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=LXEO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();